Theseus Pharmaceuticals I... (THRX)
NASDAQ: THRX
· Real-Time Price · USD
4.07
0.01 (0.25%)
At close: Feb 13, 2024, 9:59 PM
Theseus Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2.18 | -6.89 | -7.76 | -3.12 | -4.13 | -4.73 | -10.59 | -13.14 | -22.6 | -24.47 | -26.34 |
PEG Ratio | 0.25 | -0.4 | 0.28 | -0.22 | -0.2 | -0.64 | -0.85 | -0.92 | -2.15 | -4.41 | -0.41 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.52 | 1.74 | 1.53 | 0.93 | 1.02 | 0.93 | 1.85 | 1.85 | -13.29 | -15.12 | n/a |
P/FCF Ratio | -10.64 | -40.6 | -20.21 | -19.38 | -30.7 | -25.13 | -57.19 | -45.94 | -125.23 | -98.6 | -90.64 |
P/OCF Ratio | -10.69 | -40.65 | -20.2 | -19.4 | -30.97 | -26.23 | -57.39 | -45.89 | -125.23 | -98.6 | -90.64 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | n/a | n/a | n/a | n/a |
Quick Ratio | 29.93 | 27.83 | 35.72 | 17.79 | 27.54 | 43.66 | 43.65 | 67.38 | 16.11 | 25.04 | n/a |
Current Ratio | 29.93 | 27.83 | 35.72 | 17.79 | 27.54 | 43.66 | 43.65 | 67.38 | 16.11 | 25.04 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -9.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.06 | -0.06 | -0.05 | -0.07 | -0.06 | -0.05 | -0.04 | -0.04 | 0.15 | 0.15 | n/a |
Return on Assets | -0.06 | -0.06 | -0.05 | -0.07 | -0.06 | -0.05 | -0.04 | -0.03 | -0.08 | -0.07 | n/a |
Return on Invested Capital | -0.07 | -0.07 | -0.06 | -0.08 | -0.07 | -0.05 | -0.04 | -0.04 | -0.08 | -0.07 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |